Navan Inc. Class A Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Navan Inc. Class A Common Stock trades at $23.63 (market cap $6.01B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.72 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 9.8× Navan Inc. Class A Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while Navan Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Navan Inc. Class A Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| NAVN | TAK | |
|---|---|---|
Market Cap | $6.01B | $58.74B |
Volume | 2,990,425 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $30.58 | $19.05 |
52-Week Low | $8.51 | $13.23 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.36B | $86.65B |
Dividend Yield | — | 3.33% |
Trailing returns across standard periods
Latest headlines on both assets
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →